Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-12-22
1998-10-13
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483061, 5483107, A61K 31415, C07D23518, C07D40312
Patent
active
058212582
ABSTRACT:
Described herein is an anticancer agent, an antiviral agent or an antimicrobial agent which contains, as an active ingredient for acting on DNA, a compound presented by the following formula (1) or its pharmacologically acceptable salt: ##STR1##
REFERENCES:
patent: 5273991 (1993-12-01), Lee
Arcamone et al, "Synthesis, DNA-Binding Properties, and Antitumor Activity of Novel Distamycin Derivatives", J. Med. Chem., 1989, 32, pp. 774-778.
Oesterle et al, "Chemical Modifications of Aminonaphthalenesulfonic Acid Derivatives Increase Effectively and Specificity of Reverse Transcriptase Inhibition and Change Mode of Action of Reverse Transcriptase and DNA Polymerase Alpha Inhibition", Antiviral Research, 1993, vol. 22, No. 2-3, pp. 107-119.
F. Arcamone et al, "Structure and Synthesis of Distamyci A", Nature, vol. 203, pp. 1064-1065, 1964.
Teng et al, "The Molecular Structure of the Complex of Hoechst 33258 and the DNA Dodecamer d(CGCGAATTCGCG)", Nucleic Acids Research, vol. 16, pp.2671-2690, 1988.
Baker et al, "Sequence-Specific Cleavage of Double-Helical DNA. N-Bromoacetyldistamycin", J. Am. Chem. Soc., vol. 107, pp. 8266-8268, 1985.
Fukui et al, "Methioninemethylsulfonium Salts", Fukui, Kanai, and Kitano, vol. 25, pp. 804-807, 1959.
Valu et al, "DNA-Directed Alkylating Agents. 3. Structure-Activity Relationships for Acridine-Liked Aniline Mustards: Consequences of Varying the Length of the Linker Chain", J. Med. Chem., vol. 33, pp. 3014-3019, 1990.
Palmer et al, "Hypoxia-Selective Antitumor Agents. 3. Relationships Between Structure and Cytotoxicity Against Cultured Tumor Cells for Substituted N,N-Bis(2-chloroethyl)anilines", J. Med. Chem., vol. 33, pp. 112-121, 1990.
Everett et al, "Aryl-2-Halogenoalkylamines, Part II", Everett and Ross, 420, pp. 19720-1983, 1948.
Alley et al, "Feasibility of Drug Screening With Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay", Cancer Research, vol. 48, pp. 589-601, 1988.
Sklyarova et al., Khim.-Farm. Zh. (1988), 22(6), pp. 697-699 and CA 110:192707 (1989).
Sklyarova et al., J. Org. Chem. USSR, 25 (1989), 1.2, pp. 169-171.
Edatsugi Hajime
Iwata Daiji
Kohno Hiroshi
Matsunaga Akio
Nakajima Yuki
Mitsui Chemicals Inc.
Richter Johann
Stockton Laura L.
LandOfFree
Phenylbenzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylbenzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylbenzimidazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-313524